Recordati Industria Chimica e Farmaceutica SpA
MIL:REC

Watchlist Manager
Recordati Industria Chimica e Farmaceutica SpA Logo
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Watchlist
Price: 46.64 EUR -0.13% Market Closed
Market Cap: €9.8B

Operating Margin

26.8%
Current
Declining
by 0.5%
vs 3-y average of 27.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
26.8%
=
Operating Income
€663.5m
/
Revenue
€2.5B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
26.8%
=
Operating Income
€663.5m
/
Revenue
€2.5B

Peer Comparison

Country Company Market Cap Operating
Margin
IT
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
9.6B EUR
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
524.9B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
220.8B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.5B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...

Market Distribution

Higher than 88% of companies in Italy
Percentile
88th
Based on 1 199 companies
88th percentile
26.8%
Low
-79 476% — 3.9%
Typical Range
3.9% — 14.4%
High
14.4% — 813.7%
Distribution Statistics
Italy
Min -79 476%
30th Percentile 3.9%
Median 8.7%
70th Percentile 14.4%
Max 813.7%

Recordati Industria Chimica e Farmaceutica SpA
Glance View

Nestled within the vibrant landscape of the Italian pharmaceutical industry, Recordati Industria Chimica e Farmaceutica SpA has carved a distinct identity over its nearly century-long journey. Founded in 1926 by Giovanni Recordati, the company has evolved from a small chemical laboratory into one of Europe's prominent players in pharmaceuticals. The heart of Recordati's operations lies in its robust portfolio, which spans pharmaceuticals, rare disease treatments, and consumer health products. With a commitment to innovation and diligent R&D efforts, Recordati continuously develops both proprietary drugs and generic medicines, ensuring a diverse revenue stream. Aiming to address crucial health challenges, the company has strategically expanded its rare disease segment, exploring niche markets with high unmet medical needs. Recordati's business model is a sophisticated blend of internal development, strategic acquisitions, and partnerships. The company's success largely hinges on its ability to identify and integrate complementary businesses, enhancing its global footprint. Through a network covering Western Europe, Central and Eastern Europe, as well as North America and emerging markets, Recordati not only distributes its own line of medications but also collaborates with other pharmaceutical entities to commercialize their products. This strategic expansion, coupled with a proactive approach to fostering market-specific adaptations, supports a steady flow of revenue. Revenue sustainability is further bolstered by a responsive supply chain and targeted marketing strategies that strengthen Recordati's competitive stance in the pharmaceutical sector worldwide.

REC Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
26.8%
=
Operating Income
€663.5m
/
Revenue
€2.5B
What is Recordati Industria Chimica e Farmaceutica SpA's current Operating Margin?

The current Operating Margin for Recordati Industria Chimica e Farmaceutica SpA is 26.8%, which is below its 3-year median of 27.3%.

How has Operating Margin changed over time?

Over the last 3 years, Recordati Industria Chimica e Farmaceutica SpA’s Operating Margin has decreased from 30.1% to 26.8%. During this period, it reached a low of 26.7% on Mar 31, 2023 and a high of 30.1% on May 30, 2022.

Back to Top